Clinical Trial Update: Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy [Phase 1, Phase 2]

View source ↗

Summary

A neoadjuvant regimen combining hormonal therapy with chemoimmunotherapy in HER2-positive and ER-positive breast cancer was studied in Phase 1/2 and subsequentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Western Regional Medical Center | Conditions: HER2-positive Breast Cancer, ER-positive Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-10-25